Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for ...

Medically reviewed by Danielle Weiss, MD Type 2 diabetes is not an autoimmune condition, while type 1 diabetes is. Though new ...

Harvard Medical School scientists have identified a key protein in the human immune system that drives inflammatory and ...

The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial.

New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...

Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response ...

Now, researchers from Yale have found that a specific bacterium, called Enterococcus gallinarum, can move from the gut to ...

For the first time, researchers outline new therapeutic avenues for a rare patient group with unmet clinical needs, paving ...

Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company’s ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

What is Celiac disease? Celiac disease is caused when a person’s immune system reacts abnormally to a protein called gluten.